News
Important Only
Should Investors Buy SoundHound AI Stock on the Dip?
SoundHound AI (NASDAQ: SOUN) is making excellent progress in adding innovative services for customers.Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. See the 10 stocks »*Stock prices used were the afternoon prices of Jan. 9,...The Motley Fool
Mon, Jan 13
Retiring Soon? 4 Important Things to Know About Social Security in 2025
Social Security is a big deal, delivering retirement benefits to more than 50 million retirees annually along with disability and survivor benefits to millions more. The retiree benefits alone total nearly $100 billion annually.Social Security is vital, too. According to the Social Security Administ...The Motley Fool
Mon, Jan 13
BUZZ-U.S. Steel rises on delayed enforcement of order blocking deal with Nippon Steel
** Shares of U.S. Steel X.N rise 1.6% in premarket trading ** Biden administration delays enforcement of order blocking U.S. Steel's merger with Japan's Nippon Steel 5401.T until June ** President Joe Biden blocked the $14.9 billion acquisition of the American steel firm by Nippon Steel on national ...Reuters
Mon, Jan 13
The Best S&P 500 ETF to Invest $500 In Right Now
The S&P 500 had a fantastic 2024, roaring into a bull market and going on to deliver a 23% gain. And that's after already climbing in the double digits the previous year. Of course, even though the bull market is going strong, it's impossible for anyone to predict with 100% accuracy whether the inde...The Motley Fool
Mon, Jan 13
Warren Buffett Is Set to Collect $4.5 Billion in Annual Dividend Income From 7 Magnificent Stocks
Few if any money managers command the attention of investors quite like the Oracle of Omaha, Warren Buffett. Since taking over as Berkshire Hathaway's (NYSE: BRK.A)(NYSE: BRK.B) CEO six decades ago, Buffett has overseen a cumulative return in his company's Class A shares of 5,477,866%, as of the clo...The Motley Fool
Mon, Jan 13
Which Vanguard ETF Is Most Likely to Soar During Trump's First Year Back in Office?
We're only seven days away from the inauguration of Donald Trump as the 47th U.S. president. Investors have been speculating about which stocks might perform the best in a second Trump administration since the November election, and even before then. Identifying exchange-traded funds (ETFs) that cou...The Motley Fool
Mon, Jan 13
My 3 Highest-Conviction Growth Stocks to Buy in 2025
Arguably the three most important words in investing are: I don't know. Acknowledging that you don't know for sure what will happen with any investment can save you from a heap of trouble.However, this doesn't mean you can't have strong opinions about certain investments. I'm quite confident that so...The Motley Fool
Mon, Jan 13
Frontage Announces Co-CEO Promotions
EXTON, Pa., / January 13, 2025 / – Frontage Holdings Corporation (SEHK stock code: 1521) announced on January 6 2025 that Dr. Abdul Mutlib has decided to step aside from his current role as CEO of the company to facilitate the Company’s leadership succession planning and that Chief Strategy Officer Dr. Wentao Zhang and President Dr. John Lin have been promoted to Co-CEOs of the company effective today. Going forward, Dr. Mutlib will assume an advisory role as the Chief Scientific and Strategy Officer, ensuring a smooth transition and business continuity. Dr. Mutlib will remain committed to Frontage for at least a year, advising and supporting the Frontage leadership team, contribute to Frontage’s growth plans across various business units, and participate in business development, especially in early drug discovery and development.Dr. Zhang has been a valued Frontage executive for nearly 4 years, following Frontage’s acquisition of Quintara Discovery, which Dr. Zhang founded in 2012. Likewise, Dr. Lin has been a core member of Frontage’s executive team for over 17 years, most recently serving as President of Frontage Laboratories, Inc.In announcing the promotions, Dr. Song Li, Executive Chairman on the Board, said, “Since its founding over 20 years ago, Frontage has been a remarkable and dynamic organization. We have continued to enjoy impressive growth in many areas during Abdul’s successful tenure as CEO and we are grateful for his vision and leadership over the past two years. I believe he has guided the company through a period that has presented some challenges to the CRO industry and, through his steady stewardship, has positioned us for ongoing success.”Dr. Li continued, “Wentao and John are incredibly talented leaders – each of them have proven track records of delivering impressive results for Frontage, while inspiring their colleagues at Frontage and our partners throughout the industry. They both have many years of executive-level experience and have been working closely with Abdul in preparation for assuming their new responsibilities as Co-CEOs. I respect Abdul’s decision to step aside from his role as CEO and I am thankful that he will be remaining with the organization as Chief Scientific and Strategy Officer – a role in which he will offer support to Wentao and John, while also offering guidance to the company in strategic and corporate development initiatives. As Co-CEOs, Wentao and John will have clearly delineated roles and responsibilities, and I believe their history of effective collaboration presents a unique leadership opportunity for Frontage. On behalf of the board of directors, it is my privilege to announce their elevation to their new roles.”In announcing his decision to step aside as CEO, Dr. Mutlib said, “As I approach my 65th birthday, the time is right for me to transition from day-to-day duties of actively managing the Frontage organization. Serving our clients, employees, and stockholders as CEO for the past 2 years has been an honor and privilege. The support of Frontage’s Board of Directors and Frontage’s extraordinary employees has helped us navigate through a challenging environment while delivering the impressive results that our clients have come to expect from us. I am looking forward to continuing to serve Frontage in my role as Chief Scientific and Strategy Officer, a role in which I will offer my full support to Wentao and John. I have complete confidence in their ability to lead Frontage into the future, and I congratulate them as my successors.”Dr. Zhang said, “I am honored to succeed Abdul as Frontage’s Co-CEO. He has demonstrated remarkable leadership for the company over the last 2 years. I am fortunate to continue to work with Abdul in my new role and am humbled by the confidence that Abdul, Song, the Frontage board of directors, and our dedicated employees have placed in me. My Co-CEO John and I have worked together for many years, and it is the honor of my business career to collaborate with him in leading our company.”Dr. Lin said, “I would like to express my thanks to Song and the board of directors for the opportunity to lead this outstanding organization with Wentao as Co-CEOs. Abdul has set an impressive example in leadership over the past two years, and I am grateful for the opportunity to continue to work with him. Wentao is a remarkable colleague, and we will endeavor to jointly lead Frontage with humility, integrity and care, as we maintain our focus on serving our customers, enhancing profitability and creating long-term value for all of our stakeholders.”About Frontage (www.frontagelab.com )Frontage Holdings Corp (1521.HK), together with its wholly owned subsidiaries including Frontage Laboratories, Inc., is a global Contract Research Organization (CRO) that provides integrated, science-driven, product development services from drug discovery to late-phase clinical process to enable biopharmaceutical companies to achieve their development goals.Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safetyand toxicology assessment, and early-phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of new molecules through development and to successfully file global regulatory submissions. For more details visit www.frontagelab.com.13/01/2025 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.comEQS
Mon, Jan 13
The Best E-Commerce Stock to Invest $500 In Right Now
MercadoLibre (NASDAQ: MELI) has been a great stock for patient long-term investors but has been in a slump since the company's latest earnings report. In the roughly two months since then, MercadoLibre has fallen by about 20%.While the initial decline was due to missing expectations on the bottom li...The Motley Fool
Mon, Jan 13
BUZZ-Frontline rises as sanctions boost demand for crude carriers
** Shares in Norwegian oil tanker group Frontline FRO.OL rise 3.8% as tighter U.S. sanctions on Russian and Iranian fleets boost demand for large crude carriers** Sanctions on shadow fleets could potentially retire tankers from service and drive up demand for vessels operated by non-Russian traders ...Reuters
Mon, Jan 13
Should You Buy Rivian While It's Below $20?
Over the past 12 months, Rivian (NASDAQ: RIVN) shares have been stuck under $20. That's a far cry from their all-time high of around $130. If you've been looking for a growth stock with significant upside potential, this could be your chance. However, there are two things in particular that you shou...The Motley Fool
Mon, Jan 13
Why Marvell Stock Soared 83% in 2024
Shares of Marvell Technology (NASDAQ: MRVL), which makes data infrastructure semiconductors, soared 83.1% in 2024, according to data from S&P Global Market Intelligence. For context, that's more than triple the S&P 500 index's 25% return and nearly three times the tech-heavy Nasdaq Composite index's...The Motley Fool
Mon, Jan 13
A Big Social Security Change Just Signed by President Biden Comes With Bad News for Retirees
On Jan. 5, President Joe Biden signed into law the Social Security Fairness Act. That means nearly 3 million public-sector workers with government pensions will receive larger Social Security benefits, with the average increase estimated at $360 per month. But the new law also comes with bad news fo...The Motley Fool
Mon, Jan 13
1 Unstoppable Stock That Could Join Nvidia, Apple, and Microsoft in the $3 Trillion Club in 2025
American stock exchanges are home to nine technology companies with valuations of $1 trillion or more, but only three have graduated into the $3 trillion club so far:Apple: $3.56 trillionNvidia: $3.34 trillionMicrosoft: $3.11 trillionAlphabet (NASDAQ: GOOG)(NASDAQ: GOOGL) is the world's fourth-large...The Motley Fool
Mon, Jan 13
GLOBAL MARKETS-Stocks tumble as traders cast doubt on 2025 rate cut
LONDON, Jan 13 (Reuters) - Global stocks fell on Monday, while the dollar hit 26-month peaks following a bumper U.S. jobs report that prompted investors to question if interest rates will fall at all this year, just as earnings season is about to get underway.
Reuters
Mon, Jan 13
BUZZ-COMMENT-Surging option demand shows gravity of GBP's predicament
Jan 13 (Reuters) - Demand for GBP-related FX options has surged over the last week, taking their premiums to ever new highs since March 2023 and highlighting the gravity of the perilous situation in which the British pound now finds itself. FX options are forward looking and thrive on FX volatility ...Reuters
Mon, Jan 13
LIVE MARKETS-STOXX falters as rate-sensitive tech names drag, oil lifts
STOXX 600 down 1%Traders digest strong US jobs reportTech names falterOil stocks surgeWelcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.comSTOXX FALTERS AS RATE-SENSITIVE TECH NAMES DRAG, ...Reuters
Mon, Jan 13
Prediction: This Artificial Intelligence (AI) Software Company Will Split Its Stock in 2025
Last year, technology stocks put on yet another terrific performance. Of course, the main catalyst fueling tech stocks to new heights was ongoing euphoria surrounding all things artificial intelligence (AI).One company that fared particularly well was enterprise software giant ServiceNow (NYSE: NOW)...The Motley Fool
Mon, Jan 13
3 Reasons to Buy This Index Fund and Hold for a Lifetime
When investors think about owning the market, the go-to exchange-traded fund (ETF) or mutual fund is usually an S&P 500 (SNPINDEX: ^GSPC) index tracker. That's not a bad call at all, but there are other ways to get exposure to the market that are a bit more nuanced. Here's a look at why the S&P 500 ...The Motley Fool
Mon, Jan 13
Russia's net forex sales rise to equivalent of 4.76 bln roubles per day
MOSCOW, Jan 13 (Reuters) - Russia's finance ministry said on Monday it would decrease its purchases of foreign currency and gold in the month ahead, a move that will increase the state's overall forex sales, providing support for the rouble.The finance ministry said its purchases of foreign currenci...Reuters
Mon, Jan 13
